Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.
Chen H, Na R, Packiam VT, Conran CA, Jiang D, Tao S, Yu H, Lin X, Meng W, Zheng SL, Brendler CB, Helfand BT, Xu J.
Chen H, et al. Among authors: packiam vt.
Prostate. 2017 Aug;77(11):1179-1186. doi: 10.1002/pros.23369. Epub 2017 Jul 2.
Prostate. 2017.
PMID: 28670847
Free PMC article.
Clinical Trial.